Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature

NCT01201551 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Primary Vascular Dysregulation

Interventions

DRUG: Brimonidine
DRUG: Latanoprost
DRUG: Placebo

Sponsor

University Hospital, Basel, Switzerland